Bruce & Co’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $947K | Buy |
789,188
+60,000
| +8% | +$73K | 0.27% | 34 |
|
|
2025
Q4 | $717K | Hold |
729,188
| – | – | 0.22% | 35 |
|
|
2025
Q3 | $919K | Buy |
729,188
+300,000
| +70% | +$323K | 0.28% | 34 |
|
|
2025
Q2 | $481K | Sell |
429,188
-120,812
| -22% | -$140K | 0.16% | 39 |
|
|
2025
Q1 | $435K | Buy |
550,000
+200,000
| +57% | +$245K | 0.14% | 38 |
|
|
2024
Q4 | $578K | Hold |
350,000
| – | – | 0.19% | 36 |
|
|
2024
Q3 | $1.23M | Buy |
350,000
+50,000
| +17% | +$195K | 0.36% | 32 |
|
|
2024
Q2 | $984K | Buy |
300,000
+157,000
| +110% | +$687K | 0.32% | 32 |
|
|
2024
Q1 | $1.05M | Hold |
143,000
| – | – | 0.35% | 30 |
|
|
2023
Q4 | $535K | Sell |
143,000
-57,000
| -29% | -$135K | 0.19% | 34 |
|
|
2023
Q3 | $424K | Hold |
200,000
| – | – | 0.14% | 35 |
|
|
2023
Q2 | $956K | Hold |
200,000
| – | – | 0.27% | 28 |
|
|
2023
Q1 | $1.14M | Buy |
200,000
+143,000
| +251% | +$863K | 0.31% | 27 |
|
|
2022
Q4 | $575K | Hold |
57,000
| – | – | 0.15% | 32 |
|
|
2022
Q3 | $1.28M | Hold |
57,000
| – | – | 0.35% | 27 |
|
|
2022
Q2 | $1.41M | Hold |
57,000
| – | – | 0.33% | 27 |
|
|
2022
Q1 | $2.21M | Hold |
57,000
| – | – | 0.45% | 25 |
|
|
2021
Q4 | $3.33M | Hold |
57,000
| – | – | 0.67% | 23 |
|
|
2021
Q3 | $3.38M | Sell |
57,000
-5,000
| -8% | -$392K | 0.72% | 24 |
|
|
2021
Q2 | $5.38M | Sell |
62,000
-3,000
| -5% | -$242K | 1.03% | 20 |
|
|
2021
Q1 | $5.36M | Sell |
65,000
-10,000
| -13% | -$958K | 1% | 21 |
|
|
2020
Q4 | $6.82M | Sell |
75,000
-25,000
| -25% | -$1.55M | 1.31% | 20 |
|
|
2020
Q3 | $4M | Hold |
100,000
| – | – | 0.83% | 24 |
|
|
2020
Q2 | $3.43M | Buy |
100,000
+50,000
| +100% | +$1.49M | 0.75% | 24 |
|
|
2020
Q1 | $1.11M | Hold |
50,000
| – | – | 0.26% | 34 |
|
|
2019
Q4 | $978K | Buy |
+50,000
| New | +$794K | 0.19% | 37 |
|
Other funds holding FATE
RG
VCM
VPM
JJ
